Oxolife Is A Biotechnology Company Based In Barcelonaspainfounded In 2013 By Dragna S Arbat And Drignasi Canalsthe Company Is Dedicated To Improving Female Fertilitywith A Focus On Enhancing Embryo Implantation And Restoring Ovulationoxolife Aims To Address Unmet Medical Needs In Assisted Reproductive Technologiesartthe Primary Product Of Oxolife Is Oxo 001A Non Hormonal Oral Treatment Designed To Improve Embryo Implantation Ratesthis Treatment Has Shown Promising Results In Preclinical Trials And Has Completed A Phase I Study With A Strong Safety Profilecurrentlyoxolife Is Conducting A Phase Ii Clinical Trial To Further Evaluate The Efficacy Of Oxo 001Particularly For Women Undergoing Art And Those With Infertility Related To Polycystic Ovary Syndromepcosoxolife Collaborates With Academic Institutions To Advance Its Research And Has Successfully Raised Funding To Support Its Clinical Trialsthe Company Has Received Recognition For Its Innovative Work In Women S Health Technologiespositioning It As A Leader In Reproductive Medicine
No conferences found for this company.
| Company Name | Oxolife Sl |
| Country |
Spain
|
| Address | N/A |
| Telephone | N/A |
| N/A |
